Delivery Order SPE2DE24DA017-SPE2D626F4500
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,146.32 delivery order to Arthrex Inc. on October 17, 2025, for the Arthrex Angel PRP Kit (US Tray), with an ultimate completion date of October 22, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, reflecting Arthrex's competitive standing as a prime contractor. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters as a leading manufacturer of...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, has been awarded a delivery order valued at $5,365.80 for the Arthrex Angel PRP Kit (US Tray) by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on October 23, 2025, with an ultimate completion date of October 28, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. This delivery order was awarded without a set-aside designation, reflecting Arthrex's...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $10,731.60 to Arthrex Inc. on September 9, 2025, for the supply of ARTHREX ANGEL PRP Kits (US Tray). This fixed-price contract with economic price adjustment is set to be completed by September 12, 2025, and will be performed at Arthrex's Naples, Florida facility. The award represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $5,365.80 for the ARTHREX ANGEL PRP KIT (US TRAY) on September 12, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 17, 2025. This award was issued under a non-set-aside procurement by the Defense Logistics Agency's Medical Supply Chain, a defense-focused...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $8,943 delivery order from the Defense Logistics Agency's Medical Supply Chain on September 17, 2025, for the ARTHREX ANGEL PRP Kit. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 22, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $8,255.40 for the ARTHREX ANGEL PRP KIT (US TRAY) from the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, with an ultimate completion date of September 12, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal medical...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,430.88 on September 23, 2025, for the supply of ARTHREX ANGEL PRP Kit (US Tray). The order, which is due for completion by September 26, 2025, was issued under a fixed-price contract with economic price adjustment provisions and carries no set-aside designation. This delivery order was funded through the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc. was awarded a delivery order valued at $2,146.32 by the Defense Logistics Agency's Medical Supply Chain on June 24, 2025, for the delivery of Arthrex ANGEL PRP Kits (US Tray). The contract, classified as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by June 27, 2025, and will be performed at Arthrex's facility in Naples, Florida. This award carries no set-aside designation, reflecting Arthrex's strong competitive position in...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a $8,943 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the ARTHREX ANGEL PRP Kit (US Tray). The delivery order, which carries an ultimate completion date of July 30, 2025, was awarded without set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The work will be performed in Naples,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,154.40 to Arthrex Inc. on August 25, 2025, for the supply of ARTHREX ANGEL PRP Kit (US Tray). This fixed-price delivery order with economic price adjustment is scheduled for completion by August 28, 2025, and will be performed in Naples, Florida, where Arthrex maintains its headquarters. The award was made without a set-aside designation, reflecting Arthrex's competitive standing in the federal...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F4500Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $8,943 delivery order to Arthrex Inc. for the Arthrex Angel PRP Kit (US Tray) on October 23, 2025, with completion scheduled for October 28, 2025. This fixed-price contract with economic price adjustment represents performance to be completed at Arthrex's Naples, Florida facility. The award carries no set-aside designation, reflecting the contractor's established competitive position in federal orthopedic procurement. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency, valued at approximately $471 million and effective through September 2029. The master contract authorizes procurement of comprehensive orthopedic products and surgical technologies supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. Arthrex, headquartered in Naples, Florida, is a leading manufacturer of minimally invasive orthopedic medical devices, implants, and biologics, and has demonstrated substantial federal contracting capability through direct supplier relationships with the VA and DoD without subcontractor involvement on individual task orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 10/23/25 |